Prenetics Global Limited (PRENW)
USD 0.01
(19.0%)
USD 0.01
(19.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 60.73 Million USD | -50.88% |
| 2022 | 124.88 Million USD | 7.22% |
| 2021 | 116.47 Million USD | 358.99% |
| 2020 | 25.37 Million USD | 21.16% |
| 2019 | 20.94 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 13.68 Million USD | -7.86% |
| 2024 Q2 | 15.12 Million USD | 5.02% |
| 2023 Q1 | 21.14 Million USD | 7.55% |
| 2023 FY | 61.34 Million USD | -50.88% |
| 2023 Q3 | 16.39 Million USD | 4.37% |
| 2023 Q2 | 15.7 Million USD | -25.72% |
| 2023 Q4 | 14.85 Million USD | -9.38% |
| 2022 Q2 | 128.58 Million USD | 251.71% |
| 2022 Q1 | 36.55 Million USD | -32.87% |
| 2022 Q4 | 19.66 Million USD | -30.94% |
| 2022 FY | 124.88 Million USD | 7.22% |
| 2022 Q3 | 28.47 Million USD | -77.85% |
| 2021 Q2 | 19.79 Million USD | 75.06% |
| 2021 FY | 116.47 Million USD | 358.99% |
| 2021 Q1 | 11.3 Million USD | -21.38% |
| 2021 Q4 | 54.45 Million USD | 76.11% |
| 2021 Q3 | 30.92 Million USD | 56.19% |
| 2020 Q2 | 3.76 Million USD | -29.98% |
| 2020 Q1 | 5.37 Million USD | 0.0% |
| 2020 FY | 25.37 Million USD | 21.16% |
| 2020 Q4 | 14.38 Million USD | 115.67% |
| 2020 Q3 | 6.66 Million USD | 77.16% |
| 2019 FY | 20.94 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bionano Genomics, Inc. | 148.99 Million USD | 59.235% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -273.258% |
| CareDx, Inc | 277.76 Million USD | 78.134% |
| Exact Sciences Corporation | 2.06 Billion USD | 97.052% |
| Exagen Inc. | 52.29 Million USD | -16.147% |
| Inotiv, Inc. | 246.9 Million USD | 75.401% |
| Guardant Health, Inc. | 901.62 Million USD | 93.264% |
| Biodesix, Inc. | 77.41 Million USD | 21.548% |
| BioNexus Gene Lab Corp. | 3.92 Million USD | -1448.184% |
| Precipio, Inc. | 13.63 Million USD | -345.348% |
| iSpecimen Inc. | 16.27 Million USD | -273.138% |
| Natera, Inc. | 938.98 Million USD | 93.532% |
| Aspira Women's Health Inc. | 24.11 Million USD | -151.873% |
| Standard BioTools Inc. | 113.48 Million USD | 46.482% |
| 23andMe Holding Co. | 420.73 Million USD | 85.564% |
| Castle Biosciences, Inc. | 242.78 Million USD | 74.983% |
| Personalis, Inc. | 128.14 Million USD | 52.603% |
| Aclaris Therapeutics, Inc. | 110.52 Million USD | 45.047% |
| Applied DNA Sciences, Inc. | 16.48 Million USD | -268.397% |
| OpGen, Inc. | 30.65 Million USD | -98.11% |
| T2 Biosystems, Inc. | 41.49 Million USD | -46.374% |
| Myriad Genetics, Inc. | 600.1 Million USD | 89.879% |
| ICON Public Limited Company | 755.64 Million USD | 91.962% |
| NeoGenomics, Inc. | 341.25 Million USD | 82.202% |
| Star Equity Holdings, Inc. | 16.27 Million USD | -273.258% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 94.442% |
| RadNet, Inc. | 268.87 Million USD | 77.411% |
| MDxHealth SA | 71.25 Million USD | 14.763% |
| Psychemedics Corporation | 11.33 Million USD | -435.88% |
| Illumina, Inc. | 3.81 Billion USD | 98.407% |
| Check-Cap Ltd. | 19.28 Million USD | -214.91% |
| Twist Bioscience Corporation | 354.18 Million USD | 82.851% |
| DarioHealth Corp. | 62.17 Million USD | 2.31% |
| Fulgent Genetics, Inc. | 171.9 Million USD | 64.669% |
| Sera Prognostics, Inc. | 39.91 Million USD | -52.157% |
| ENDRA Life Sciences Inc. | 10.52 Million USD | -477.304% |
| OPKO Health, Inc. | 574.68 Million USD | 89.431% |
| Medpace Holdings, Inc. | 187.68 Million USD | 67.638% |
| Neogen Corporation | 405.23 Million USD | 85.012% |
| Intelligent Bio Solutions Inc. | 11.7 Million USD | -418.726% |
| Prenetics Global Limited | 60.73 Million USD | 0.0% |
| Mainz Biomed B.V. | 27.15 Million USD | -123.672% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -592.957% |
| Trinity Biotech plc | 46.49 Million USD | -30.63% |
| Neuronetics, Inc. | 82.25 Million USD | 26.164% |
| Sotera Health Company | 300.46 Million USD | 79.786% |
| bioAffinity Technologies, Inc. | 8.76 Million USD | -592.957% |